GBD 2019 Ageing Collaborators. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. Bmj. 2022;376: e068208.

Chesnaye NC, et al. The impact of population ageing on the burden of chronic kidney disease. Nat Rev Nephrol. 2024;20(9):569–85.

Article  PubMed  Google Scholar 

Guo J, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7(1):391.

Article  PubMed  PubMed Central  Google Scholar 

López-Otín C, et al. Meta-hallmarks of aging and cancer. Cell Metab. 2023;35(1):12–35.

Article  PubMed  Google Scholar 

López-Otín C, et al. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243–78.

Article  PubMed  Google Scholar 

Bhadra M, et al. Alternative splicing in aging and longevity. Hum Genet. 2020;139(3):357–69.

Article  PubMed  Google Scholar 

Deschênes M, Chabot B. The emerging role of alternative splicing in senescence and aging. Aging Cell. 2017;16(5):918–33.

Article  PubMed  PubMed Central  Google Scholar 

Harries LW, et al. Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing. Aging Cell. 2011;10(5):868–78.

Article  PubMed  Google Scholar 

Holly AC, et al. Changes in splicing factor expression are associated with advancing age in man. Mech Ageing Dev. 2013;134(9):356–66.

Article  PubMed  PubMed Central  Google Scholar 

Heintz C, et al. Splicing factor 1 modulates dietary restriction and TORC1 pathway longevity in C. elegans. Nature. 2017;541(7635):102–6.

Article  PubMed  Google Scholar 

Stroustrup N, et al. The temporal scaling of Caenorhabditis elegans ageing. Nature. 2016;530(7588):103–7.

Article  PubMed  PubMed Central  Google Scholar 

Palikaras K, Lionaki E, Tavernarakis N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature. 2015;521(7553):525–8.

Article  PubMed  Google Scholar 

Kenyon CJ. The genetics of ageing. Nature. 2010;464(7288):504–12.

Article  PubMed  Google Scholar 

Kuroyanagi H, et al. Position-dependent and neuron-specific splicing regulation by the CELF family RNA-binding protein UNC-75 in Caenorhabditis elegans. Nucleic Acids Res. 2013;41(7):4015–25.

Article  PubMed  PubMed Central  Google Scholar 

Ehsanian R, Van Waes C, Feller SM. Beyond DNA binding - a review of the potential mechanisms mediating quinacrine’s therapeutic activities in parasitic infections, inflammation, and cancers. Cell Commun Signal. 2011;9:13.

Article  PubMed  PubMed Central  Google Scholar 

Esmail MM, et al. Hepatoprotective and neuroprotective effects of quinacrine against bile duct ligation-induced hepatic encephalopathy in rats: role of bone morphogenetic proteins signaling. Life Sci. 2024;359:123229.

Article  PubMed  Google Scholar 

Gorbachev AV, et al. Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation. Eur J Immunol. 2007;37(8):2257–67.

Article  PubMed  Google Scholar 

Dol-Gleizes F, et al. Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2009;29(1):12–8.

Article  PubMed  Google Scholar 

Mukhopadhyay P, et al. CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. Cardiovasc Res. 2010;85(4):773–84.

Article  PubMed  Google Scholar 

Tam J, et al. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. J Clin Invest. 2010;120(8):2953–66.

Article  PubMed  PubMed Central  Google Scholar 

Jorgacevic B, et al. Rimonabant improves oxidative/nitrosative stress in mice with nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2015;2015:842108.

Article  PubMed  PubMed Central  Google Scholar 

Li X, et al. Quinacrine attenuates diet-induced obesity by inhibiting adipogenesis via activation of AMPK signaling. Eur J Pharmacol. 2023;938:175432.

Article  PubMed  Google Scholar 

Després JP, Golay A, Sjöström L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005;353(20):2121–34.

Article  PubMed  Google Scholar 

Szabo R, et al. Potential implications of rimonabant on age-related oxidative stress and inflammation. Antioxidants (Basel). 2022;11(1):162.

Article  PubMed  Google Scholar 

Franceschi C, et al. Inflammaging and “Garb-aging.” Trends Endocrinol Metab. 2017;28(3):199–212.

Article  PubMed  Google Scholar 

Baralle M, Romano M. Age-related alternative splicing: driver or passenger in the aging process? Cells. 2023;12(24):2819.

Article  PubMed  PubMed Central  Google Scholar 

van der Keyl H, et al. Caenorhabditis elegans sqt-3 mutants have mutations in the col-1 collagen gene. Dev Dyn. 1994;201(1):86–94.

Article  PubMed  Google Scholar 

Wang MC, et al. Gene pathways that delay Caenorhabditis elegans reproductive senescence. PLoS Genet. 2014;10(12):e1004752.

Article  PubMed  PubMed Central  Google Scholar 

Tanenbaum L, Tuffanelli DL. Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine. Arch Dermatol. 1980;116(5):587–91.

Article  PubMed  Google Scholar 

Christensen R, et al. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007;370(9600):1706–13.

Article  PubMed  Google Scholar 

Green CL, Lamming DW, Fontana L. Molecular mechanisms of dietary restriction promoting health and longevity. Nat Rev Mol Cell Biol. 2022;23(1):56–73.

Article  PubMed  Google Scholar 

Wang Z, et al. ACS-20/FATP4 mediates the anti-ageing effect of dietary restriction in C. elegans. Nat Commun. 2023;14(1):7683.

Article  PubMed  PubMed Central  Google Scholar 

Hartman JH, et al. Xenobiotic metabolism and transport in Caenorhabditis elegans. J Toxicol Environ Health B Crit Rev. 2021;24(2):51–94.

Article  PubMed  PubMed Central  Google Scholar 

Leung MC, et al. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci. 2008;106(1):5–28.

Article  PubMed  PubMed Central  Google Scholar 

Lim SYM, et al. CYP35 family in Caenorhabditis elegans biological processes: fatty acid synthesis, xenobiotic metabolism, and stress responses. Arch Toxicol. 2022;96(12):3163–74.

Article  PubMed  Google Scholar 

Larigot L, et al. Cytochromes P450 of Caenorhabditis elegans: implication in Biological Functions and Metabolism of Xenobiotics. Biomolecules. 2022;12(3):342.

Article  PubMed  PubMed Central  Google Scholar 

Lim SYM, et al. CYP14 family in Caenorhabditis elegans: mitochondrial function, detoxification, and lifespan. J Appl Toxicol. 2024;44(11):1647–56.